Beigene Ltd ADR (NQ: BGNE )Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
4 Analysts Have This to Say About BeiGene
January 20, 2023
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
January 20, 2023
BeiGene Earnings Perspective: Return On Capital Employed
December 12, 2022
What 5 Analyst Ratings Have To Say About BeiGene
December 12, 2022
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Why Shares of BeiGene Were Up Wednesday
December 01, 2022
BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia
January 19, 2023
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating
December 08, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|